Sector Chart Alaunos Therapeutics, Inc.

Stocks

TCRT

US98973P3091

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-23 EDT			5-day change	1st Jan Change
2.150 ^USD	-0.46%		-4.02%	-33.44%

05-26	Alaunos Therapeutics Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies	CI
05-18	Alaunos reports preclinical ALN1003 data showing effects on insulin-resistance-related biomarkers and liver histology in diet-induced obesity models	RE

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
ALAUNOS THERAPEUTICS, INC.	5.21M	-	-	-	-	-
ARGENX SE	57.55B
WUXI APPTEC CO., LTD.	47.08B
BIONTECH SE	22.92B					-
INSMED INCORPORATED	22.14B					-
WUXI BIOLOGICS (CAYMAN) INC.	16.33B